ESR1 and breast cancer: In this context, even though the treatment of MCF-7 cells with exogenous NGB does not evidence promigratory effects [9], the present data open the intriguing possibility that the positive modulation of intracellular NGB levels can take part in the promotion of breast cancer cell motility through the activation of ERα [37,38].